Skip to main content

Table 2 Results of multivariate linear regression for factors predicting the change in best corrected visual acuity (BCVA) in logMAR units at 12 months

From: Visual and anatomical outcomes associated with treat-and-extend administration of intravitreal aflibercept for neovascular age-related macular degeneration

Predictor

ß

p value

Age

0.16

0.019 (*)

Baseline BCVA

− 0.42

9.43e-09 (***)

Baseline CRT

− 0.0063

0.93

Number of injections

− 0.16

0.022 (*)

Presence of SRF

0.014

0.84

Presence of IRF

− 0.044

0.54

  1. BCVA best corrected visual acuity; CRT central retinal thickness; SRF subretinal fluid; IRF intraretinal fluid
  2. p  <  0.001 (***), p  <  0.01 (**), p  <  0.05 (*)
Back to article page

International Journal of Retina and Vitreous

ISSN: 2056-9920

Contact us